The persistent threat of pneumonia as a significant cause of death and illness worldwide, particularly among children under the age of five. The emergence of antibiotic-resistant strains of bacteria and the spread of the COVID-19 pandemic have heightened concerns about the disease. While vaccines are an effective way to prevent pneumonia, challenges persist in managing and preventing the disease, including limited access to healthcare and resources, the high cost of preventative measures, and the need for better diagnostic tools and treatment options. Despite these challenges, efforts must continue to address this significant public health threat and protect vulnerable populations.
